twenty dogs with naturally occurring metastatic tumors were treated with anticoagulants ( warfarin ) or platelet enzyme inhibitor drugs ( dipyridamole , dipyridamole plus aspirin , ra233 , sulfinpyrazone , or a combination of ra233 and sulfinpyrazone ) to determine if tumor-related reductions in platelet survival and concentration could be reversed .
C0012582
dipyridamole
C0732279
dipyridamole